Effect of IFN-γ stimulation on expression of intercellular adhesion molecule-1 (ICAM-1) on alveolar macrophages in patients with non-small cell lung cancer

Journal of Interferon and Cytokine Research

Volumn 26, Issue 3, 2006, Pages 190-195

  Da̧browska, Marta ^a   Grubek Jaworska, H ^a   Hoser, G ^b   Domagala Kulawik J ^a   Krenke, R ^a   Chazan, R ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSTIMULATION; LUNG ALVEOLUS MACROPHAGE; LUNG DISEASE; LUNG LAVAGE; LUNG NON SMALL CELL CANCER; LYMPHOCYTE COUNT; MALE; NEUTROPHIL COUNT; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOKING; STATISTICAL ANALYSIS; TUMOR CELL DESTRUCTION; VOLUNTEER;

ADULT; AGED; BRONCHOALVEOLAR LAVAGE FLUID; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; CELLS, CULTURED; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON TYPE II; LUNG NEOPLASMS; MACROPHAGES, ALVEOLAR; MALE; MIDDLE AGED; RECOMBINANT PROTEINS;

EID: 33645412357     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2006.26.190     Document Type: Article

References (29)

1. Staunon DE, Marlin SD, Stratowa C, Dustin ML, Springer TA. Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin supergene families. Cell 1988;52:925-933.
2. Rothlein R, Mainolfi EA, Czajkowski M, Marlin SD. A form of circulating 1CAM-1 in human serum. J. Immunol. 1991;147:3788-3793.
3. Van de Stolpe A, van der Saag PT. Intercellular adhesion molecule-1. J. Mol. Med. 1995;74:13-33.
4. Thomson AW, Satoh S, Nussler AK, Tamura K, Woo J, Gavaler J, van Thiel DH. Circulating intercellular adhesion molecule-1 (ICAM-1) in autoimmune liver disease and evidence for the production of ICAM-1 by cytokine-stimulated human hepatocytes. Clin. Exp. Immunol. 1994;95:83-90.
5. Baumer I, Zissel G, Schlaak M, Muller-Quernheim J. Shed soluble ICAM-1 molecules in bronchoalveolar lavage cell supernatants and serum of patients with pulmonary sarcoidosis. Lung 1997;175:105-116.
6. Guzman J, Izumi T, Nagai S, Costabel U. ICAM-1 and integrin expression on isolated human alveolar type II pneumocytes. Eur. Respir. J. 1994;7:736-739.
7. Montefort S, Lai SK, Kapahi P, Leung J, Lai KN, Chan HS, Haskaro DO, Howarth PH, Holgate ST. Circulating adhesion molecules in asthma. Am. J. Respir. Crit. Care Med. 1994;149:1149-1152.
8. Dobashi K, Aihara M, Araki T, Shimizu Y, Utsugi M, Iizuka K, Murata Y, Hamuro J, Nakazawa T, Mori M. Regulation of LPS induced IL-12 production by IFN-gamma and IL-4 through intracellular glutathione status in human alveolar macrophages. Clin. Exp. Immunol. 2001;124:290-296.
9. Galve-de Rochemonteix B, Nicod LP, Dayer JM. Tumor necrosis factor soluble receptor 75: the principal receptor form released by human alveolar macrophages and monocytes in the presence of interferon gamma. Am. J. Respir. Cell. Mol. Biol. 1996;14:279-287.
10. Harkins MS, Moseley PL, Iwamoto GK. Regulation of CD23 in the chronic inflammatory response in asthma: a role for interferon-gamma and heat shock protein 70 in the Th2 environment. Ann. Allergy Asthma Immunol. 2003;91:567-574.
11. Calvi SA, Soares AM, Peracoli MT, Franco M, Riuz RL, Marconde-Machado J, Fecchio D, Mattos MC, Mendes RP. Study of bronchoalveolar lavage fluid in paracoccidioidomycosis: cytopathology and alveolar macrophage function in response to gamma interferon: comparison with blood monocytes. Microbes Infect. 2003;5:1373-1379.
12. Boehm U, Klamp T, Groot M, Howard JC. Cellular responses to interferon-gamma. Annu. Rev. Immunol. 1997;15:749-795.
13. Eifuku R, Yoshimatsu T, Yoshino I, Takenoyama M, Imahayashi S, So T, Hanagiri T, Nomoto K, Yasumoto K. Heterogeneous response patterns of alveolar macrophages from patients with lung cancer by stimulation with interferon-gamma. Jpn. J. Clin. Oncol. 2000;30:295-300.
14. Halme M, Maasilta P, Repo H, Leirisalo-Repo M, Taskinen E, Mattson K, Cantell K. Subcutaneously administered recombinant interferon-gamma in humans: pharmacokinetics and effects on chemiluminescence responses of alveolar macrophages, blood neutrophils, and monocytes. J. Immunother. Emphasis Tumor Immunol. 1994;15:283-291.
15. Fattal-German M, Le Roy Ladurie F, Cerrina J, Lecerf F, Berrih-Aknin S. Modulation of ICAM-1 expression in human alveolar macrophages in vitro. Eur. Respir. J. 1996;9:463-471.
16. Ahn MC, Siziopikou KP, Plate JMD, Casey L, Silver M, Harris JE, Braun DP. Modulation of tumoricidal function in alveolar macrophages from lung cancer patients by interleukin-6. Cancer Immunol. Immunother. 1997;45:37-44.
17. Kawatsu H, Hasegawa Y, Takagi E, Shimokata K. Human alveolar macrophages of anergic patients with lung cancer lack the responsiveness to recombinant interferon gamma. Chest 1991;100:1277-1280.
18. Kessler R, Dumont S, Weitzenblum E, Poindron P. Antiproliferative properties of human alveolar macrophages. Respiration 1998;65:363-368.
19. McDonald CF, Atkins RC. Defective cytostatic activity of pulmonary alveolar macrophages in primary lung cancer. Chest 1990;98:881-885.
20. Siziopikou KP, Harris JE, Casey L, Nawas Y, Braun DP. Impaired tumoricidal function of alveolar macrophages from patients with non-small cell lung cancer. Cancer 1991;68:1035-1044.
21. Siziopikou KP, Ahn MC, Casey L, Silver M, Harris JE, Braun DP. Augmentation of impaired tumoricidal function in alveolar macrophages from lung cancer patients by cocultivation with allogenic, but not autologous lymphocytes. Cancer Immunol. Immunother. 1997;45:29-36.
22. McDonald CF, Hutchinson P, Atkins RC. Delineation of pulmonary alveolar macrophage subpopulations by flow cytometry in normal subjects and in patients with lung cancer. Clin. Exp. Immunol. 1993;91:126-130.
23. Mountain CF. The international system for staging lung cancer. Semin. Surg. Oncol. 2000;18:106-115.
24. Klech H, Hutter C. Technical recommendations and guidelines for bronchoalveolar lavage (BAL). Eur. Respir. J. 1989;2:561-585.
25. al-Sarireh B, Eremin O. Tumour-associated macrophages (TAMS): disordered function, immune suppression and progressive tumour growth. J. R. Coll. Surg. Edinb. 2000;45:1-16.
26. Okubo A, Sone S, Singh SM. Ogura T. Production of tumor necrosis factor-alpha by alveolar macrophages of lung cancer patients. Jpn. J. Cancer Res. 1990;81:403-409.
27. Liu CY, Wang CH, Chen TC, Lin HC, Yu CT, Kuo HP. Increased level of exhaled nitric oxide and up-regulation of inducible nitric oxide synthase in patients with primary lung cancer. Br. J. Cancer 1998;78:534-541.
28. Staal van den Brekel AJ, Dentener MA, Drent M, Ten Velde GPM, Burman WA, Wouters FM. The enhanced inflammatory response in non-small cell lung carcinoma is not reflected in the alveolar compartment. Respir. Med. 1998;92:76-83.
29. Hoser G, Grubek-Jaworska H, Droszcz P, Domagala-Kulawik J, Da̧browska M, Chazan R. Reactivity of alveolar macrophages in lung cancer patients and healthy subjects-surface ICAM-1 after IFN-γ stimulation in vitro. Folila Histochem. Cytobiol. 2002;40:103-104.